This page contains a Flash digital edition of a book.
for a particular part. Tere are three phases of qualifications that medical device manu- facturers must perform to prove their process is valid to the FDA, according to Nate Rose, Applications Engineer- ing Manager for Opti- cal Gaging Products (OGP; Rochester, NY). Installation Quali-


fication (IQ) is the first phase, Operational Qualification (OQ) is the second, and Per- formance Qualification (PQ) is the third and final phase. IQ verifies the system is installed and calibrated ac- cording to the manufacturer’s specifications. IQ also includes verification of the environment in which the equipment is installed, and other factors such as documentation, traceabil- ity, utilities, and contact materials. Operational Qualification (OQ) is a procedure to verify that


Scalable solutions for collecting, storing, and managing quality data are so stringent for the FDA, that Mitutoyo ensures its Measurlink software meets the agency’s requirements as its baseline.


the intended requirements. “It’s effective for them because they do not need to purchase the artifacts or redevelop de- tailed procedures and documentation,” Rose said. OGP developed a package of validation routines using its


a metrology device operates as intended and is effective and re- producible. Te OQ tests include standard operating conditions, verification of accuracy and repeatability (using NIST traceable standards other than those used for calibration) for all axes and sensors. OQ also verifies other aspects of the FDA requirements, including access control and tracking, data management and archiving, preventitive maintenance schedules and other factors. “Te results of an OQ are documented and maintained as a permanent record of the system’s performance.” Rose said. Te final phase, PQ, for measurement systems, typically


includes verification of gage repeatability and reproducibility using typical sample parts and their respective measurement fixtures, routines and procedures. Although OGP is primarily a supplier of metrology equip-


ment and soſtware, it developed its validation services to help small and medium-sized enterprises through their IQ, OQ, and PQ phases. “Our customers asked us to provide what we call the FDA Service, because many companies do not have the staff or artifacts to conduct the IQ and OQ on their own,” he said. For its FDA Service, OGP created procedures and specialized NIST traceable artifacts designed to verify the equipment, sensors and soſtware they offer. Tese might be chrome-on-glass line scale artifacts, or specialized gages for verifying specific geometric construction capabilities in the soſtware. Te resulting test procedures verify the system meets


SmartFeature soſtware. OGP specifically designed it for multi- sensor metrology programming and support. “We really could not provide the FDA Service without SmartFeature soſtware. It provides the user access control, logging, audit, and editing control of the measurement routines that FDA requires,” Rose said. “We need to log who inspected something, when, and track any modification of the inspection routines.” At a more fundamental level, medical device manufactur-


ers also need to control and evaluate machine tool perfor- mance to meet certain requirements of CFR Title 21, accord- ing to Clive Warren of Renishaw (Hoffman Estates, IL). “If a device manufacturer is machining parts, they are expected to know the capabilities of their machines prior to produc- ing those parts,” he said. “Te theory is they should not be producing any defective parts—even if they end up inspecting them 100% anyway.” Renishaw offers their QC20W device for ballbar analysis as a key tool for determining machining capa- bility. Te QC-20W measures to the standardized circularity test as defined in international standards such as ISO 230-4. “As an approved methodology for determining the contour-


ing performance of machine tools, it helps meet the report- ing requirements for CFR Title 21,” he said. Tis is critical on complex parts such as knee or hip replacements, with complex curved and contoured surfaces, according to Warren. “You need to know how all the different interrelated machine functions are performing and what their effect may be on workpiece quality.


Medical Manufacturing 2014 79


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96  |  Page 97  |  Page 98  |  Page 99  |  Page 100  |  Page 101  |  Page 102  |  Page 103  |  Page 104  |  Page 105  |  Page 106  |  Page 107  |  Page 108  |  Page 109  |  Page 110  |  Page 111  |  Page 112  |  Page 113  |  Page 114  |  Page 115  |  Page 116  |  Page 117  |  Page 118  |  Page 119  |  Page 120  |  Page 121  |  Page 122  |  Page 123  |  Page 124  |  Page 125  |  Page 126  |  Page 127  |  Page 128  |  Page 129  |  Page 130  |  Page 131  |  Page 132  |  Page 133  |  Page 134  |  Page 135  |  Page 136  |  Page 137  |  Page 138  |  Page 139  |  Page 140  |  Page 141  |  Page 142  |  Page 143  |  Page 144  |  Page 145  |  Page 146  |  Page 147  |  Page 148  |  Page 149  |  Page 150  |  Page 151  |  Page 152  |  Page 153  |  Page 154  |  Page 155  |  Page 156  |  Page 157  |  Page 158  |  Page 159  |  Page 160  |  Page 161  |  Page 162  |  Page 163  |  Page 164  |  Page 165  |  Page 166  |  Page 167  |  Page 168  |  Page 169  |  Page 170  |  Page 171  |  Page 172  |  Page 173  |  Page 174  |  Page 175  |  Page 176  |  Page 177  |  Page 178  |  Page 179  |  Page 180  |  Page 181  |  Page 182  |  Page 183  |  Page 184  |  Page 185  |  Page 186  |  Page 187  |  Page 188  |  Page 189  |  Page 190  |  Page 191  |  Page 192  |  Page 193  |  Page 194  |  Page 195  |  Page 196  |  Page 197  |  Page 198  |  Page 199  |  Page 200  |  Page 201  |  Page 202  |  Page 203  |  Page 204  |  Page 205  |  Page 206  |  Page 207  |  Page 208  |  Page 209  |  Page 210  |  Page 211  |  Page 212  |  Page 213  |  Page 214  |  Page 215  |  Page 216